Open Access Critical Evidence Review

Glycated hemoglobin versus oral glucose tolerance test in identifying individuals with prediabetes in the Qatari population - A review of the evidence

In the Qatari population, OGTT and HbA1c classified nearly half of the participants differently. Those who were prediabetic only according to the OGTT had lower beta-cell function and a worse metabolic profile; those who were positive only for HbA1c appeared more similar to normoglycemic individuals. This is cross-sectional evidence, useful but not prognostic, which needs to be confirmed longitudinally in other populations.

Cite this article
Bitonti, M. (2026). Glycated hemoglobin versus oral glucose tolerance test in identifying individuals with prediabetes in the Qatari population - A review of the evidence. Life Science Hub Journal. DOI: 10.5281/zenodo.24160088. https://lifesciencehub.info/en/glycated-hemoglobin-versus-oral-glucose-tolerance-test-in-identifying-individuals-with-prediabetes
LIFE Science Hub - Journal of Science · 2026 / Nov

DOI 10.5281/zenodo.24160088

Article history
Dates
  • Published 12/11/2026
  • Updated 12/11/2026
Revisions
  1. v1.0 — 12/11/2026 Initial publication of the article.

LIFE Science Hub keeps a record of every published version of the article to ensure editorial transparency. Future revisions will appear here.

Scientific still-life with laboratory vials and subtle biological symbols, illustrating the comparison between HbA1c and OGTT in prediabetes.
Visual comparison between two pathways for assessing prediabetes: the glycemic average reflected by HbA1c and the dynamic response to the OGTT. The image highlights how the tests can identify different metabolic profiles in the studied population.

ABSTRACT

The study compared two methods for identifying prediabetes in 446 Qatari adults without known diabetes: glycated hemoglobin (HbA1c, an indicator of average blood sugar over the previous months) and the oral glucose tolerance test (OGTT, a test that measures the body's response to 75 grams of glucose). The two criteria showed low concordance. Individuals classified as having prediabetes only by the OGTT exhibited lower estimated pancreatic beta-cell function, a higher prevalence of metabolic syndrome, and a higher estimated future diabetes risk score compared to those identified only by HbA1c.

In the narrative of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi, the study contributes to the passage stating that an isolated positive HbA1c result may not correspond to the same pathophysiological profile detected by an impaired glycemic response after a glucose load. Independent studies confirm that OGTT and HbA1c may select different groups and that the OGTT can detect alterations not captured by HbA1c. However, a large Chinese cohort shows that even elevated HbA1c with a normal OGTT can be associated with reduced beta-cell function. The most prudent conclusion is, therefore, that the tests describe different aspects of glucose regulation and that the clinical context and the population studied are decisive.

Analyzed study

Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population

Iskandar S, Migahid A, Kamal D, Megahed O, DeFronzo RA, Zirie M, Jayyousi A, Al Jaidah M, Abdul-Ghani M

BMC endocrine disorders, 2019

DOI: 10.1186/s12902-019-0412-1

PMID: 31438915

PMCID: PMC6704621

The research question was whether HbA1c and OGTT identified the same Qatari adults as having prediabetes and, crucially, whether the groups identified by the two tests had a comparable metabolic profile. The hypothesis was that the dynamic glucose tolerance test could recognize individuals with glucose regulation impairments not evident through the HbA1c value alone.

The relevance to the "Choosing to Live in Health or Disease" section by Dr. A. Colonnese and R. Panzironi is specific: the publication does not demonstrate the entire natural history of diabetes, but it documents that, in this population, individuals positive only for HbA1c and those positive only for OGTT were not metabolically equivalent. The central point is the comparison between the function of pancreatic beta cells, which are the cells that produce insulin in response to glucose.

As this is a cross-sectional study based on measurements collected at a single point in time, it can show differences between groups but cannot establish whether one test necessarily identifies an earlier or more advanced stage of the disease. Furthermore, the future risk of diabetes was not observed directly over time: it was estimated using a predictive model.

Materials and methods of the original study

The authors performed a retrospective analysis of data collected during pre-employment health screenings at Qatar Petroleum. The study included 446 adults of Arab descent with no known diagnosis of type 2 diabetes, who were in good general health and not taking any medications known to alter glucose tolerance. Inclusion criteria required an HbA1c level below 6.5%, a fasting plasma glycemia below 126 mg/dl, and a two-hour glycemia below 200 mg/dl.

All participants underwent a 75-gram OGTT after 10-12 hours of fasting. Glucose and insulin levels were measured while fasting and two hours after the load. HbA1c was measured using high-performance liquid chromatography, a laboratory technique used to quantify different forms of hemoglobin. Prediabetes according to OGTT was defined as a fasting glycemia between 100 and 125 mg/dl and/or a two-hour glycemia between 140 and 199 mg/dl. According to HbA1c, it was defined by values between 5.7% and 6.4%.

Insulin sensitivity and beta-cell function were estimated using HOMA indices, which are calculations derived from fasting glycemia and insulin. Beta-cell function was expressed as the product of estimated insulin secretion and the reciprocal of insulin resistance. Metabolic syndrome was also identified according to ATP III criteria, and the 7-8 year diabetes risk was estimated using the Stern model. The exact data collection period is not reported in the available material. No prospective clinical follow-up is reported.

Results

According to the OGTT, 296 out of 446 participants, or 66%, had prediabetes; 150, or 34%, had normal glucose tolerance. Using HbA1c instead, 200 people, or 45%, were classified as prediabetic and 246 as normoglycemic. Only 150 participants were classified as having prediabetes by both tests, and 100 as normal by both.

In practice, 196 out of 446 people, or 44%, received conflicting classifications from the two methods. The kappa coefficient, an index that measures how much two classifications agree beyond chance, was 0.15 with P less than 0.0001: the concordance was statistically different from chance, but very low in practical terms. The correlations between HbA1c and fasting glycemia (r=0.16) and between HbA1c and two-hour glycemia (r=0.19) were also weak.

The data most relevant to the book concerns the discordant groups. People with prediabetes according to the OGTT but with an HbA1c below 5.7% had an estimated beta-cell function of 34 ± 1, very close to that of the group positive by both criteria, which was 33 ± 1. People positive only for HbA1c had a beta-cell function of 51 ± 2, closer to the group normal by both tests, which was 55 ± 1. The overall difference between the four groups was statistically significant, with P less than 0.0001.

The other indicators followed the same trend. The prevalence of metabolic syndrome was 62% in subjects positive only for the OGTT and 20% in subjects positive only for HbA1c. The Stern score, which estimates rather than directly measures the future probability of diabetes, was 16.1 ± 1 in the OGTT-only group and 19.8 ± 0.9 in the HbA1c-only group; both groups had values higher than the group normal by both criteria, which was 8.3 ± 0.6. However, the authors emphasize that this score does not replace the actual observation of diabetes incidence over time.

Interpretation

In simple terms, the two tests do not capture the exact same aspect of metabolism. HbA1c summarizes average glucose exposure over time, while the OGTT observes how the body handles a rapid increase in glucose. A person can therefore have a normal average glycemia and, at the same time, an abnormal response after a glucose load.

In the study analyzed, the segment actually documented is this: among Qatari adults, prediabetes defined solely by the OGTT was associated with lower estimated beta-cell function and a higher frequency of metabolic syndrome compared to prediabetes defined solely by HbA1c. The result supports the statement in the book that many subjects positive exclusively for HbA1c may present relatively preserved beta-cell function compared to those who show alterations in the OGTT.

However, this observation does not justify considering HbA1c a useless test, nor does it prove that every subject with elevated HbA1c and a normal OGTT is metabolically healthy. HOMA indices are indirect estimates of beta-cell function, and the cross-sectional study does not demonstrate a causal sequence. Furthermore, the differences may depend on age, body composition, geographic origin, conditions that modify HbA1c, and the diagnostic thresholds used.

Independent confirming evidence

An independent cohort of 522 Mexican-American adults provided confirmation that is particularly close to the passage discussed. All participants underwent a 75-gram OGTT and more detailed assessments of beta-cell function, based on insulin secretion and insulin sensitivity. In participants with normal glucose tolerance, beta-cell function was comparable both with HbA1c below 5.7% and with HbA1c between 5.7% and 6.4%. Conversely, the presence of impaired fasting glycemia or impaired glucose tolerance was associated with a marked reduction in beta-cell function, regardless of HbA1c levels. This separate cohort directly supports the idea that the impairment documented by the OGTT may identify a beta-cell defect that the HbA1c range alone does not fully describe [1]. The limitation is that this remains a cross-sectional analysis of a specific population.

A retrospective study conducted in Thailand on 512 people at high metabolic risk confirmed that HbA1c and OGTT can classify different groups. The OGTT identified diabetes in 19.7% of participants, compared to 11.1% identified by HbA1c. For diabetes, an HbA1c of 6.5% or higher showed a sensitivity of 32% and a specificity of 94% compared to the OGTT; this means that the test was rarely positive in subjects without diabetes according to the adopted reference, but it failed to recognize a significant portion of subjects who were positive on the OGTT. Concordance for prediabetes was also low, with a kappa of 0.154 [2]. The study did not directly measure beta-cell function, so it confirms the diagnostic discordance but not the cellular mechanism observed in the Qatari population.

In a cohort of 1,044 people without known diabetes undergoing coronary angiography, the combined use of HbA1c and OGTT revealed further differences in estimated beta-cell function. Among the 432 participants with a normal OGTT, an HbA1c of 42 mmol/mol or higher was associated with a lower HOMA-beta compared to an HbA1c below 42 mmol/mol: 107 ± 82 versus 132 ± 96, with P=0.018. Among the 423 participants with prediabetes according to the OGTT, an HbA1c of 48 mmol/mol or higher was associated with a lower HOMA-beta: 91 ± 52 versus 120 ± 88, with P=0.003 [3]. This study confirms that combining markers can describe different metabolic subgroups; however, it concerns patients with suspected or known coronary artery disease and cannot be automatically generalized to the entire population.

Conflicting evidence

Significant conflicting evidence comes from a Chinese cohort of 3,517 middle-aged or older individuals, all with normal glucose tolerance according to an OGTT. The authors compared 1,640 participants with an HbA1c of 5.7% or higher with 1,877 participants with an HbA1c below 5.7%. After statistical adjustments, the group with isolated elevated HbA1c maintained lower insulin sensitivity as assessed by the Matsuda index and a lower early disposition index, a measure of the beta cells' ability to compensate for insulin resistance [4].

This result contrasts with the clearer interpretation that isolated HbA1c positivity generally indicates preserved beta-cell function. Instead, it shows that elevated HbA1c, even with a normal OGTT, can be associated with early metabolic impairment. The differences compared to the Qatari study may depend on the population, age, selection criteria, the method used to estimate beta-cell function, and the fact that the Chinese cohort exclusively included people who were already normal according to the OGTT. No directly conflicting evidence sufficiently relevant to demonstrate the opposite of the discordance between HbA1c and OGTT has been identified; this does not prove the absence of contrary results.

Summary table of evidence

The table distinguishes the original study from independent research and shows that discordance between tests is repeatedly observed, while the pathophysiological significance of isolated elevated HbA1c varies across populations.

Reference Study type Population or model Main result Direction of evidence Strength of evidence
Original study Retrospective cross-sectional observational 446 Qatari adults without known diabetes OGTT-only prediabetes was associated with lower estimated beta-cell function and more frequent metabolic syndrome compared to HbA1c-only prediabetes. direct confirmation moderate
[1] Cross-sectional observational 522 Mexican-American adults who underwent OGTT IFG or IGT were associated with a marked reduction in beta-cell function independently of HbA1c; HbA1c 5.7-6.4% with normal OGTT did not show the same reduction. direct confirmation moderate
[2] Retrospective cross-sectional observational 512 Thai patients at high metabolic risk HbA1c and OGTT showed low concordance; HbA1c identified fewer cases of diabetes compared to OGTT. indirect confirmation moderate
[3] Cross-sectional observational 1,044 patients without known diabetes who underwent coronary angiography Adding HbA1c to OGTT distinguished subgroups with lower HOMA-beta. biologically consistent evidence moderate
[4] Cross-sectional observational 3,517 Chinese adults with normal OGTT Isolated elevated HbA1c was associated with lower insulin sensitivity and lower early beta-cell function. discordant evidence moderate

Confirmation of the evidence

Claim in the book

In the section dedicated to two-hour plasma glycemia, "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi states that many individuals who tested positive only for HbA1c showed substantially preserved beta-cell function. The text therefore proposes that OGTT and HbA1c do not merely identify different populations, but may intercept different pathophysiological profiles.

Oral glucose tolerance test → impaired glycemic response to OGTT → reduced estimated beta-cell function and worse metabolic profile → greater metabolic vulnerability

The publication subject to the Evidence Review was used in the book to support the following point: in the Qatari population, people who tested positive only for HbA1c had more preserved estimated beta-cell function compared to people with prediabetes identified only by the OGTT; the two tests, therefore, did not define metabolically overlapping groups.

The correspondence between the book passage and the original study is direct: the comparison of the four groups classified by OGTT and HbA1c showed that the OGTT-only group had a lower estimated beta-cell function than the HbA1c-only group. A distinct cohort of Mexican-American adults confirmed the core of this narrative: alterations in fasting or post-load glycemia were associated with a marked impairment of beta-cell function, regardless of the HbA1c value [1].

Independent literature also supports the previous step in the chain: HbA1c and OGTT frequently classify different people. In the Thai cohort, the low concordance and the lower ability of HbA1c to identify cases defined by the OGTT replicate the discordance observed in Qatar [2]. Furthermore, the study on patients undergoing coronary angiography shows that integrating HbA1c and OGTT can recognize further differences in estimated beta-cell function [3].

However, the narrative must be delimited. In a Chinese cohort, even isolated elevated HbA1c with normal OGTT was associated with lower insulin sensitivity and reduced early beta-cell function [4]. Therefore, the formulation most faithful to the evidence is not that the HbA1c-only group always has preserved beta-cell function, but that in the Qatari sample, it presented a profile that was on average less compromised than the OGTT-only group. “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi is consistent with this interpretation when the passage is referred to the context studied and not universalized.

Overall level of confirmation

MODERATE CONFIRMATION

The finding is documented directly in the original study and is confirmed by an independent cohort that links OGTT abnormalities to poorer beta-cell function. The low concordance between tests is replicated in other populations, but the conflicting evidence regarding isolated elevated HbA1c and the lack of follow-up in the original work require caution.

Conclusions

The study analyzed clearly shows that, in the observed Qatari population, HbA1c and OGTT were not interchangeable for identifying prediabetes. The group identified only by the OGTT showed lower estimated beta-cell function and a higher frequency of metabolic syndrome compared to the group positive only for HbA1c.

Independent literature moderately confirms that the OGTT can detect alterations in glucose regulation and beta-cell function not fully represented by HbA1c. However, the apparently preserved beta-cell function in subjects with isolated elevated HbA1c is not a universal finding. The available evidence therefore supports an integrated and contextualized approach, without establishing that a single test is superior in every population or clinical circumstance.

Overall assessment

The narrative is moderately supported: the original study directly documents, in the Qatari sample, a less compromised profile in the group positive only for HbA1c compared to the group positive only for the OGTT. The discrepancy between tests is well supported, while the biological significance of isolated elevated HbA1c remains dependent on the population and context.

References

[1] The Relationship Between b-Cell Function and Glycated Hemoglobin

Kanat M, Winnier D, Norton L, Arar N, Jenkinson C, DeFronzo RA, et al., 2011

Diabetes Care

[2] Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients

Thewjitcharoen Y, Jones Elizabeth A, Butadej S, Nakasatien S, Chotwanvirat P, Wanothayaroj E, et al., 2019

BMC Endocrine Disorders

[3] Testing for HbA1c, in addition to the oral glucose tolerance test, in screening for abnormal glucose regulation helps to reveal patients with early b-cell function impairment

Li YH, Sheu WHH, Lee WJ, Lee IT, Lin SY, Lee WL, et al., 2018

Clinical Chemistry and Laboratory Medicine (CCLM)

[4] Impaired b-cell function and decreased insulin sensitivity in subjects with normal oral glucose tolerance but isolated high glycosylated hemoglobin

Fu Q, Sun M, Wang Z, He W, Duan Y, Yang T, 2018

Endocrine Journal

Editorial note

Artificial Intelligence was used solely as a tool to support editorial and documentary work. All content, interpretations, bibliographic citations and conclusions have been verified, reviewed and approved by the author, who assumes full scientific responsibility for them.

The manuscript was also subject to independent peer review prior to publication.

To ensure maximum transparency, the article's complete history — including the dates of submission, review, acceptance and publication, as well as information on the peer review process — is available on the dedicated Article History page.